• SENSEX
    NIFTY 50
Business

Ranitidine recall: Patient safety is our first priority, next step depends on test results, says GSK vice-president

Updated : September 27, 2019 01:25 PM IST

It is a Rs 200-crore focus brand in India; the company to find out a way to manage the financial impact of the recall.
It’s premature to give the financial impact because we are expecting some test results, says GSK Pharma VP and South Asia MD A Vaidheesh.
Ranitidine recall: Patient safety is our first priority, next step depends on test results, says GSK vice-president
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV